Cell Therapeutics to Report First Quarter Financial Results after Market on May 2, 2013

 Cell Therapeutics to Report First Quarter Financial Results after Market on
                                 May 2, 2013

- Conference call and webcast at 4:30 p.m. Eastern Time -

PR Newswire

SEATTLE, April 24, 2013

SEATTLE, April 24, 2013 /PRNewswire/ --Cell Therapeutics, Inc. (CTI) (NASDAQ
and MTA: CTIC) announced today that it will report its first quarter financial
results on Thursday, May 2, 2013, after the close of the U.S. financial
markets. Following the announcement, members of the management team will host
a webcast conference call to discuss the results and provide a general
corporate update, at 4:30 p.m. ET (1:30 p.m. PT). Access to the event can be
obtained as follows:

Thursday, May 2
1:30 p.m. PT/4:30 p.m. ET/10:30 p.m. CET
1-877-941-6010 (domestic)
+1 480-629-9644 (international)

To access the live audio webcast or the subsequent archived recording, visit
CTI's website, www.celltherapeutics.com. Webcast and telephone replays of the
conference call will be available at approximately two hours after completion
of the call. Callers can access the replay by dialing 1-800-358-3474
(domestic) or +1 303-590-3030 (international). The access code for the replay
is #4615670. The telephone replay will be available untilThursday, May 9,
2013.

About Cell Therapeutics, Inc.

Cell Therapeutics (NASDAQ and MTA: CTIC) is a biopharmaceutical company
committed to the development and commercialization of an integrated portfolio
of oncology products aimed at making cancer more treatable. CTI is
headquartered in Seattle, WA. For additional information and to sign up for
email alerts and get RSS feeds, please visit the company's website at
www.CellTherapeutics.com.

Media and Investor Contacts:

Cell Therapeutics, Inc.

Monique Greer
+1 206.272.4343
mgreer@ctiseattle.com

Ed Bell
+1 206.272.4345
invest@ctiseattle.com

In Europe
CTI Life Sciences Limited, Milan Branch
Laura Villa
Elena Bellacicca

E: CTI_EUInvestors@CTI-Lifesciences.com
T: +39 02 89659700
F: +39 02 89659719
http://www.celltherapeutics.com/italiano



SOURCE Cell Therapeutics, Inc.

Website: http://www.celltherapeutics.com